Chen Gerun, Wu Jialin, Huang Sibo, Gong Zhenqi, Wang Huaiming
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Shantou University Medical College, Shantou, China.
Ann Med. 2025 Dec;57(1):2534098. doi: 10.1080/07853890.2025.2534098. Epub 2025 Aug 1.
Colorectal cancer (CRC) is a major global health challenge due to its high incidence and mortality rates. Understanding its epidemiological trends is essential for informing prevention and intervention strategies.
This study analyzed global, regional, and national CRC data from 2010 to 2021, focusing on age-standardized incidence, mortality, disability-adjusted life years (DALY), and associated risk factors. Data was sourced from the Global Burden of Disease (GBD) Study 2021 and stratified by the Sociodemographic Index (SDI).
Globally, CRC incidence increased by 35.91% from 1,614,410 cases in 2010 to 2,194,143 cases in 2021. The mortality rate decreased from 13.37 per 100,000 in 2010 to 12.40 per 100,000 in 2021. DALY increased by 23.94%, yet the age-standardized DALY rate (ASDR) decreased by 6.88%. Notably, high SDI regions showed a downward trend in incidence and mortality, while high-middle SDI regions experienced increasing incidence but decreasing mortality. In 2021, the highest incidence was in the Netherlands (69.80 per 100,000), and the highest mortality was in Uruguay (27.46 per 100,000). Dietary and metabolic risk factors significantly contributed to CRC burden across all SDI levels.
The study reveals a complex epidemiological landscape of CRC, marked by rising incidence but declining mortality globally. These findings highlight the urgent need for targeted public health interventions, particularly in high-risk regions and younger populations, focusing on modifiable lifestyle and socioeconomic factors. Continuous monitoring and tailored prevention strategies are critical to reducing the global burden of CRC.
由于结直肠癌(CRC)的高发病率和死亡率,它是一项重大的全球健康挑战。了解其流行病学趋势对于制定预防和干预策略至关重要。
本研究分析了2010年至2021年全球、区域和国家的结直肠癌数据,重点关注年龄标准化发病率、死亡率、伤残调整生命年(DALY)以及相关风险因素。数据来源于《2021年全球疾病负担研究》,并按社会人口学指数(SDI)进行分层。
全球范围内,结直肠癌发病率从2010年的1,614,410例增加了35.91%,至2021年达到2,194,143例。死亡率从2010年的每10万人13.37例降至2021年的每10万人12.40例。DALY增加了23.94%,但年龄标准化DALY率(ASDR)下降了6.88%。值得注意的是,高SDI地区的发病率和死亡率呈下降趋势,而高中等SDI地区发病率上升但死亡率下降。2021年,发病率最高的是荷兰(每10万人69.80例),死亡率最高的是乌拉圭(每10万人27.46例)。饮食和代谢风险因素在所有SDI水平上对结直肠癌负担都有显著贡献。
该研究揭示了结直肠癌复杂的流行病学态势,其特点是全球发病率上升但死亡率下降。这些发现凸显了针对性公共卫生干预的迫切需求,特别是在高风险地区和年轻人群中,重点关注可改变的生活方式和社会经济因素。持续监测和量身定制的预防策略对于减轻全球结直肠癌负担至关重要。